Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
about
Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipientsDonor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approachEvaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events.Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocritEvaluation of limited sampling strategies for tacrolimus.Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients.Importance of hematocrit for a tacrolimus target concentration strategy.Clinical experience with once-daily tacrolimus in de novo kidney transplant recipients from living donors in Japan: 1-year follow up.Induction of cytochrome P450 enzymes: a view on human in vivo findings.Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction.Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Clinical determinants of calcineurin inhibitor disposition: a mechanistic review.Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups.NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation.Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients.A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients.Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant.The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation.Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation.Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation.ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative ColitisIdentification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients
P2860
Q28244228-302F463B-70C6-4295-A62E-AC4FDAC35104Q33561691-183D3DEC-6E82-49E2-88A6-C4E0783CC8CCQ33574176-4E701584-8734-4677-ADFC-AA4B931A9281Q33926957-3001D5E2-8ECF-4B1D-9740-BF4CB85A2EABQ34580586-A428F3BD-3BC9-4B65-84D3-EF597EE342D9Q35612903-48EDFBD0-13C7-49D5-8D6C-6908F031D66EQ36072508-CBBB2D8B-F911-4A39-B19F-ADD40E7969D9Q36087599-656EB6AF-72E7-414D-949E-230C95273AA8Q36803391-C2182A78-187C-4D29-A82A-F83533E516A6Q37469289-65BDD82D-162A-4B0A-85E5-78534AF96B97Q37682397-841928AB-F277-406F-B349-6009591515D3Q38057372-6471A0E8-3534-4B08-920A-ECD53EF92242Q38180822-3AA3073F-45FD-4AE7-8631-642C444648EBQ38467280-6C81BF03-4521-4225-BAD6-507BB2F6D459Q38501680-8F7269AB-48D2-4879-9481-B9B548D2EEC3Q38748975-033E1D5D-D8D4-4848-A079-54639F7C0E1CQ38809767-5E19A0AC-0B22-4696-8AC5-39A21ED4A2FAQ38986439-1C0C5355-A4D2-49C2-9352-E7E9FD6EF083Q39939848-8F96B5D7-CD53-4CAC-9BAD-ACBAE0D2ADD4Q40131984-3C5D8DDA-BAB1-47C4-97A6-FFA3760563B7Q41733509-651B7B9B-D8BC-465D-AA14-22D0A9316AEAQ42622920-F793FF05-493A-4F90-BC50-F4A140E5A1E9Q45794517-027FEF45-125D-4E84-B9F8-9A20A055D252Q47242677-E9DF7A0C-725F-49A4-B8BB-42EE6612C23EQ47342870-ACA26CC7-9B89-4B2C-8856-B9E670709061Q50534806-81DEDC5B-7C7F-4ABA-9F13-87B654A64314Q51602348-D5845490-F03A-4A33-B1F0-E047FA98198DQ55129457-3B9BF217-616A-48C3-8B9E-1BA8A30F03DBQ57072058-8A75263B-2EA4-4168-AD76-764B0796FE0DQ57224790-3DD07887-9B35-4C4E-A765-EA7E06D80474
P2860
Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Time-related clinical determin ...... o renal transplant recipients.
@en
Time-related clinical determin ...... o renal transplant recipients.
@nl
type
label
Time-related clinical determin ...... o renal transplant recipients.
@en
Time-related clinical determin ...... o renal transplant recipients.
@nl
prefLabel
Time-related clinical determin ...... o renal transplant recipients.
@en
Time-related clinical determin ...... o renal transplant recipients.
@nl
P2093
P1476
Time-related clinical determin ...... o renal transplant recipients.
@en
P2093
Dirk R J Kuypers
Jacques Pirenne
Kathleen Claes
Pieter Evenepoel
Willy Coosemans
Yves Vanrenterghem
P304
P356
10.2165/00003088-200443110-00005
P577
2004-01-01T00:00:00Z
P6179
1028645114